2Labarga P,Soriano V,Vispo ME,et al.Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients[J].J Infect Dis,2007,196(5):670-676.
3Thomas DL.Hepatitis C and human immunodeficiency virus infection[J].Hepatology,2002,36(5 Suppl 1):s201-s209.
4Sherman KE,Shire NJ,Rouster SD,et al.Viral kineticsin hepatitis C or hepatitis C/human immunodeficiency virus-infected patients[J].Gastroenterology,2005,128(2):313-327.
6Voigt E,Schulz C,Klausen G,et al.Pegylated interferon alpha-2bplus ribavirin for the treatment of chronic hepatitis C in HIV coinfected patients[J].J Infect,2006,53(1):36-42.
7Van den Eynde E,Crespo M,Esteban JI,et al.Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV:A pilot trial[J].Clin Infect Dis,2009,48(8):1152-1159.
8Torriani FJ,Rodrigues-Tortes M,Reckstnoh JK,et al.Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients[J].N Engl J Med,2004,351(5):438-450.
9Ho DD,Neumann AU,Perelson AS,et al.Rapid turnover of plasma virions and CD4 lymphocytes in HIV-l infection[J].Nature,1995,373(6510):123-126.
10Mariné-Barjoan E,Saint-Paul MC,Pradier C,et al.Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients[J].AIDS,2004,18(16):2163-2170.
二级参考文献15
1Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
2Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
3Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
4Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
5Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
6Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.
7Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review[J]. Hepatology, 2002, 36(5 Suppl 1 ):S135 - S144.
8Di Ciomm no V, Russo P, Rava L, etal. Interferon alpha in the treatment of chronic hepatitis C in children: a mmeta- analysis[J] .J Viral Hepat,2003,10:210 - 214.
9Fabrizi F, Dulai G, DixitV, et al. Meta- analysis: interfeorn for the treatment of chronic hepatitis C in dialysis patients[J] .Aliment Phamacol Ther, 2003,18:1071 - 1081.
10National Institute of Health Consensus Development Conference Panel Statenent. Management of hepatitis C[J].Hepatology, 2002,36(5 Suppl 1):S3- S20.
6Luetkemeyer A, Hare CB, Stansell J, et al. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients [ J]. J Acquir Immune Defie Syndr,2006,41 ( 1 ) :31 - 36.
7Danta M, Brown D, Bhagani S;et al. Recent epidemic of acute hepa- titis C vires in HIV-positiv men who have sex with men linked to hishrisk sexual behaviours [ J ]. AIDS ( London, England ) , 2007, 21 (8) :983 -991.
8Sonano V, Sulkowski M, Bergin C, et al. Care of patients with chronic heap-titis C and HIV co-infection:recommen dations from the HIV- HCV international Panel. AIDS,2002,16 ( 8 ) :813 - 828.
